242 related articles for article (PubMed ID: 29704269)
1. Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.
Tse G; Gong M; Li G; Wong SH; Wu WKK; Wong WT; Roever L; Lee APW; Lip GYH; Wong MCS; Liu T;
Br J Clin Pharmacol; 2018 Sep; 84(9):1868-1882. PubMed ID: 29704269
[TBL] [Abstract][Full Text] [Related]
2. A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional.
Sridharan K; Sivaramakrishnan G
J Clin Pharm Ther; 2021 Jun; 46(3):640-648. PubMed ID: 33346393
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Genotype-Guided Warfarin Dosing in the Chinese Population: A Meta-analysis of Randomized Controlled Trials.
Wang F; Guo J; Zhang A
J Cardiovasc Pharmacol; 2019 Mar; 73(3):127-135. PubMed ID: 30688796
[TBL] [Abstract][Full Text] [Related]
4. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
Stergiopoulos K; Brown DL
JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of randomized controlled trials reveals an improved clinical outcome of using genotype plus clinical algorithm for warfarin dosing.
Liao Z; Feng S; Ling P; Zhang G
J Thromb Thrombolysis; 2015 Feb; 39(2):228-34. PubMed ID: 24962733
[TBL] [Abstract][Full Text] [Related]
6. Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis.
Takeuchi M; Kobayashi T; Brandão LR; Ito S
Syst Rev; 2016 Jun; 5(1):105. PubMed ID: 27334984
[TBL] [Abstract][Full Text] [Related]
7. Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.
Franchini M; Mengoli C; Cruciani M; Bonfanti C; Mannucci PM
J Thromb Haemost; 2014 Sep; 12(9):1480-7. PubMed ID: 25040440
[TBL] [Abstract][Full Text] [Related]
8. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Li J; Rodríguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple BD; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Anderson JL; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
JAMA; 2017 Sep; 318(12):1115-1124. PubMed ID: 28973620
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of genotype-guided dosing of warfarin.
Pirmohamed M; Burnside G; Eriksson N; Jorgensen AL; Toh CH; Nicholson T; Kesteven P; Christersson C; Wahlström B; Stafberg C; Zhang JE; Leathart JB; Kohnke H; Maitland-van der Zee AH; Williamson PR; Daly AK; Avery P; Kamali F; Wadelius M;
N Engl J Med; 2013 Dec; 369(24):2294-303. PubMed ID: 24251363
[TBL] [Abstract][Full Text] [Related]
10. VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.
Shaw K; Amstutz U; Hildebrand C; Rassekh SR; Hosking M; Neville K; Leeder JS; Hayden MR; Ross CJ; Carleton BC
Pediatr Blood Cancer; 2014 Jun; 61(6):1055-62. PubMed ID: 24474498
[TBL] [Abstract][Full Text] [Related]
11. Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.
Yang T; Zhou Y; Chen C; Lu M; Ma L; Cui Y
J Clin Pharm Ther; 2019 Apr; 44(2):197-208. PubMed ID: 30593674
[TBL] [Abstract][Full Text] [Related]
12. A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Kimmel SE; French B; Kasner SE; Johnson JA; Anderson JL; Gage BF; Rosenberg YD; Eby CS; Madigan RA; McBane RB; Abdel-Rahman SZ; Stevens SM; Yale S; Mohler ER; Fang MC; Shah V; Horenstein RB; Limdi NA; Muldowney JA; Gujral J; Delafontaine P; Desnick RJ; Ortel TL; Billett HH; Pendleton RC; Geller NL; Halperin JL; Goldhaber SZ; Caldwell MD; Califf RM; Ellenberg JH;
N Engl J Med; 2013 Dec; 369(24):2283-93. PubMed ID: 24251361
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.
Shi C; Yan W; Wang G; Wang F; Li Q; Lin N
PLoS One; 2015; 10(12):e0144511. PubMed ID: 26672604
[TBL] [Abstract][Full Text] [Related]
14. Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy.
Eriksson N; Wallentin L; Berglund L; Axelsson T; Connolly S; Eikelboom J; Ezekowitz M; Oldgren J; Paré G; Reilly P; Siegbahn A; Syvanen AC; Wadelius C; Yusuf S; Wadelius M
Pharmacogenomics; 2016 Aug; 17(13):1425-39. PubMed ID: 27488176
[TBL] [Abstract][Full Text] [Related]
15. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
Johnson JA; Caudle KE; Gong L; Whirl-Carrillo M; Stein CM; Scott SA; Lee MT; Gage BF; Kimmel SE; Perera MA; Anderson JL; Pirmohamed M; Klein TE; Limdi NA; Cavallari LH; Wadelius M
Clin Pharmacol Ther; 2017 Sep; 102(3):397-404. PubMed ID: 28198005
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials.
Wang X; Tang B; Zhou M; Liu L; Feng X; Wang X; Qiu K
Thromb Res; 2022 Feb; 210():42-52. PubMed ID: 34999431
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of genotype-guided warfarin anticoagulation in Chinese elderly patients with nonvalvular atrial fibrillation.
Zhu Y; Xu C; Liu J
J Clin Pharm Ther; 2020 Dec; 45(6):1466-1473. PubMed ID: 32710457
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of Randomized Controlled Trials of Genotype-Guided vs Standard Dosing of Warfarin.
Dahal K; Sharma SP; Fung E; Lee J; Moore JH; Unterborn JN; Williams SM
Chest; 2015 Sep; 148(3):701-710. PubMed ID: 25811981
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of Empiric and Pharmacogenetic Approaches in Assessment of Efficacy of Anticoagulant Therapy].
Kokh NV; Slepukhina AA; Tsvetovskaya GA; Lifshits GA
Kardiologiia; 2015; 55(4):57-60. PubMed ID: 26502504
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics-based warfarin dosing algorithm decreases time to stable anticoagulation and the risk of major hemorrhage: an updated meta-analysis of randomized controlled trials.
Wang ZQ; Zhang R; Zhang PP; Liu XH; Sun J; Wang J; Feng XF; Lu QF; Li YG
J Cardiovasc Pharmacol; 2015 Apr; 65(4):364-70. PubMed ID: 25551322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
